what happens when you stop tirzepatide Tirzepatide? Clinical Insights – PlexusDx What Happens If You Stop

Testing after your first month ensures your rapid-start advantage compounds into faster goal achievement

1998;275(5):G98492

Continuous Glucose Monitoring in People at High Risk of Diabetes and Dysglycaemia: Transforming Early Risk Detection and Personalised Care Our latest review explores how continuous glucose monitoring (CGM) could transform early detection and personalised management of diabetes risk Key Highlights: CGM reveals subtle patterns of dysglycaemia in high-risk individuals, including those with pre-symptomatic type 1 diabetes with positive islet autoantibodies, pre-type 2 diabetes or other metabolic dysfunction associated with changes in body composition, metabolic dysfunction-associated steatotic liver disease, gestational diabetes mellitus, solid organ transplantation, steroid treatment CGM-derived data are not yet validated for diabetes diagnosis, and challenges remain including limited evidence, lack of consensus on abnormal CGM values in people without diabetes, and uncertainty about optimal follow-up and management

Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and vascular endothelial growth factor (VEGF)

Tirzepatide is a dual GIP and GLP-1 receptor agonist, the first of its kind to target two metabolic pathways simultaneously

Through its interaction with key neurotransmitter systems and the hypothalamic-pituitary-adrenal (HPA) axis, DSIP peptide supports slow-wave sleep activity, helps regulate circadian rhythms, and modulates physiological stress responses